Royce & Associates LP Lexicon Pharmaceuticals, Inc. Transaction History

Royce & Associates LP

  • $10.8 Billion
  • Q1 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 08, 2021
SELL
$1.05 - $3.67 $12,961 - $45,302
-12,344 Closed
0 $0
Q3 2020

Nov 12, 2020
BUY
$1.44 - $2.1 $1,634 - $2,383
1,135 Added 10.13%
12,344 $18,000
Q2 2020

Aug 07, 2020
BUY
$1.75 - $2.3 $1,785 - $2,346
1,020 Added 10.01%
11,209 $22,000
Q1 2020

May 12, 2020
BUY
$1.8 - $4.28 $8,584 - $20,411
4,769 Added 87.99%
10,189 $20,000
Q4 2019

Feb 06, 2020
BUY
$3.16 - $5.15 $17,127 - $27,913
5,420 New
5,420 $22,000

Others Institutions Holding LXRX

# of Institutions
122
Shares Held
159M
Call Options Held
2.11M
Put Options Held
412K
View Full List

About LEXICON PHARMACEUTICALS, INC.

LXRX Quotes by TradingView
  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $313M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track This Portfolio

Track Royce & Associates LP Portfolio

Follow Royce & Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email